Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Infected RBC Size is not enlarged Size is enlarged with pale color Larger than normal, often Same with P.vivax
with fringed or irregular
Color is normal shape
Small trophozoite Same as P. vivax but with small Signet-ring form with heavy red dot (nucleus) Small, darker in color, and Same as P. vivax but with blue
(early rings) threadlike blue cytolasmic circle with and blue cytoplasmic ring generally more solid than those of cytoplasmic circle, smaller,
1 or 2 small red chromatin dots; P. falciparum; Schuffners dots thicker and heavier
double chromatin common; marginal regularly present in almost 100%
forms are common of infected cells
Parameter P. falciparum P. vivax P. ovale P. malariae
Trophozoite Remains in ring form but grows resembling Resembles closely same stage of Chromatin rounded or elongated;
small trophozoite of P. vivax in size; Like small trophozoite, with increased P. malariae but is considerably cytoplasm compact or in narrow
usually the oldest asexual stage seen in cytoplasm and ameboid activity; small larger; pigment is lighter and band across cell; dark brown
peripheral blood yellowish brown pigment granules in less conspicuous granules may have peripheral
cytoplasm, increasing with age of parasite arrangement
Gametocytes Present in peripheral blood stream; similar Microgametocyte round, occupies the whole RBC
to P. vivax crescent or sausage shape light red to pink chromatin, light to blue larger, round or oval bodies and
cytolasm, yellowish brown pigment, usually occupy the whole of the
round resembling RBC enlarged infected RBC
Macrogametocyte
small, compact, dark red eccentric chromatin,
cytoplasm dark blue, no vacuoles, abundant
dark brown pigment scattered throughout the
cytoplasm
Paramete P. falciparum P. vivax P. ovale P. malariae
r
Stages in Ring forms and All stages are All stages are present All stages are present
Peripheral gametocyte; other present
blood stages are rare
RBC affected All Stages of RBC Young RBC Young RBC Aging RBC
Life cycle
The life-cycles of Plasmodium species involve several different stages both in the insect
and the vertebrate host.
These stages include sporozoites, which are injected by the insect vector into the
vertebrate host's blood. Sporozoites infect the host liver, giving rise to merozoites and (in
some species) hypnozoites.
These move into the blood where they infect red blood cells. In the red blood cells, the
parasites can either form more merozoites to infect more red blood cells, or produce
gametocytes which are taken up by insects which feed on the vertebrate host. In the
insect host, gametocytes merge to sexually reproduce.
After sexual reproduction, parasites grow into new sporozoites, which move to the
insect's salivary glands, from which they can infect a vertebrate host bitten by the insect.
SYMPTOMS
The first symptoms of malaria are nonspecific and similar to the symptoms of a
minor systemic viral illness: headache, lassitude, fatigue, abdominal discomfort,
and muscle and joint aches, usually followed by fever, chills, perspiration, anorexia,
vomiting and worsening malaise
Feature Vivax Ovale Malariae Falciparum
Incubation Period 10-17 days 10-17 days 18-40 days 8-11 days
Severity ++ + ++ +
Initial Fever Pattern Irregular to Usually regular Continuous,
quotidian every 72hrs remittent or
quotidian
Periodicity 44-48 hrs 48-50 hrs 72 hrs 36-48 hrs
Anemia ++ + ++ ++++
CNS involvement +/- +/- +/- ++++
Nephrotic Syndrome +/- - +++ +
MANAGEMENT
Antimalarial combination therapy is the simultaneous use of two or more blood
schizontocidal medicines with independent modes of action and, thus, different
biochemical targets in the parasite.
Treatment of uncomplicated P. falciparum
Artemisinin-based combination therapies (ACTs) are the recommended treatments for
uncomplicated P. falciparum malaria.
Pregnancy
First trimester:
quinine plus clindamycin to be given for 7 days (artesunate plus clindamycin
for 7 days is indicated if this treatment fails);
an ACT is indicated only if this is the only treatment immediately available, or
if treatment with 7-day quinine plus clindamycin fails or uncertainty of
compliance with a 7-day treatment.
Treatment of Severe Malaria
Severe malaria is a medical emergency. After rapid clinical assessment and
confirmation of the diagnosis, full doses of parenteral antimalarial treatment should
be started without delay with whichever effective antimalarial is first available
For adults, artesunate IV or IM:
artemether or quinine is an acceptable alternative if parenteral artesunate is not
available.
Intravenous (IV) artesunate should be used in preference to quinine for the
treatment of severe P. falciparum malaria in adults.
Treatment of uncomplicated P. vivax malaria
Chloroquine combined with primaquine is the treatment of choice for chloroquine-
sensitive infections
In areas with chloroquine resistant P. vivax, artemisinin-based combination
therapies are recommended for the treatment of P. vivax malaria.
PHARMACOLOGY OF ANTIMALARIAL MEDICINES
CHLOROQUINE, AMODIAQUINE, SULFADOXINE, PYRIMETHAMINE, MEFLOQUINE,
ARTEMISININ AND ITS DERIVATIVES,PRIMAQUINE